Key result
Heart transplantation achieves preserved graft function and clinical stability at 17 years in arterial tortuosity syndrome.
Why the study?
Progression of arterial tortuosity syndrome to end-stage cardiomyopathy requiring orthotopic heart transplantation had not been previously reported.
Does orthotopic heart transplantation achieve long-term clinical stability in a patient with arterial tortuosity syndrome and progressive end-stage systolic heart failure?
Case Report (n=1)
Does orthotopic heart transplantation achieve long-term clinical stability in a patient with arterial tortuosity syndrome and progressive end-stage systolic heart failure?
This case report demonstrates that orthotopic heart transplantation can provide long-term clinical stability and preserved graft function for up to 17 years in patients with severe arterial tortuosity syndrome progressing to end-stage heart failure.
Answers are grounded in this paper and cite their sources.
May inform transplant decisions in arterial tortuosity syndrome; leaves open generalizability and optimal selection criteria.
Arterial tortuosity syndrome (ATS) is a rare autosomal recessive connective tissue disorder caused by pathogenic variants in SLC2A10 , characterized by elongation and tortuosity of medium- and large-sized arteries. Cardiovascular involvement commonly includes pulmonary artery disease and aortic root dilatation; progression to end-stage cardiomyopathy requiring orthotopic heart transplantation (OHT) has not been previously reported. We describe a male patient with genetically confirmed ATS who developed progressive valvular disease despite multiple interventions, including aortic valve repair and subsequent bioprosthetic aortic valve replacement. His course was marked by worsening left ventricular dilatation, systolic dysfunction, and conduction disease requiring pacemaker implantation. He developed progressive systolic heart failure and underwent a successful OHT at 9 years. Seventeen years posttransplant, he remains clinically stable with preserved graft function and persistent systemic arterial tortuosity. This case expands the cardiovascular spectrum of ATS and suggests that OHT may be a therapeutic option in severe phenotypes.
No takes yet. Share an insight, caveat, or question.
Ndukwe et al. (2026) conducted a case report in Arterial tortuosity syndrome with progressive valvular disease and end-stage systolic heart failure (n=1). Orthotopic heart transplantation (OHT) was evaluated on Clinical stability and graft function posttransplant. Orthotopic heart transplantation in a 9-year-old boy with arterial tortuosity syndrome and systolic heart failure resulted in clinical stability and preserved graft function 17 years posttransplant.
Synapse has enriched 10 related papers. Consider them for comparative context: